Many radiopharmaceuticals are available for both therapeutic and diagnostic purposes, each with unique and overlapping indications for certain illnesses, like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). The U.S. FDA has approved about 50 radiopharmaceuticals for both medicinal and diagnostic purposes; Technetium alone has more than 30 authorised compounds.
read more..